REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 140 filers reported holding REVOLUTION MEDICINES INC in Q2 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $161,707 | +9.1% | 5,842 | +5.5% | 0.01% | +14.3% |
| Q2 2023 | $148,195 | +47.1% | 5,540 | +19.1% | 0.01% | +40.0% |
| Q1 2023 | $100,719 | -9.3% | 4,650 | -0.2% | 0.01% | 0.0% |
| Q4 2022 | $111,025 | +25.6% | 4,661 | +4.0% | 0.01% | +25.0% |
| Q3 2022 | $88,365 | +16.1% | 4,481 | +14.8% | 0.00% | +33.3% |
| Q2 2022 | $76,108 | -23.6% | 3,905 | 0.0% | 0.00% | -25.0% |
| Q1 2022 | $99,617 | -76.1% | 3,905 | -76.4% | 0.00% | -33.3% |
| Q4 2021 | $416,513 | -8.5% | 16,548 | 0.0% | 0.01% | -14.3% |
| Q3 2021 | $455,235 | -13.3% | 16,548 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $525,234 | +3.1% | 16,548 | +49.0% | 0.01% | -12.5% |
| Q1 2021 | $509,681 | +12.6% | 11,109 | -2.9% | 0.01% | +14.3% |
| Q4 2020 | $452,751 | +13.8% | 11,436 | 0.0% | 0.01% | 0.0% |
| Q3 2020 | $397,973 | +154.2% | 11,436 | +130.6% | 0.01% | +133.3% |
| Q2 2020 | $156,556 | +44.1% | 4,959 | 0.0% | 0.00% | +50.0% |
| Q1 2020 | $108,652 | – | 4,959 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 5,524,031 | $151,966,000 | 28.85% |
| Ponoi II Management, LLC | 685,011 | $18,845,000 | 27.92% |
| Ponoi Management, LLC | 685,011 | $18,845,000 | 16.73% |
| Column Group LLC | 3,347,245 | $92,083,000 | 10.48% |
| TRV GP IV, LLC | 1,419,900 | $39,061,000 | 8.86% |
| Cormorant Asset Management, LP | 3,144,700 | $86,511,000 | 3.52% |
| Boxer Capital, LLC | 3,484,264 | $95,852,000 | 3.35% |
| BVF INC/IL | 2,485,049 | $68,364,000 | 2.67% |
| Casdin Capital, LLC | 2,800,000 | $77,028,000 | 1.92% |
| COMMODORE CAPITAL LP | 226,228 | $6,224,000 | 1.64% |